| 12419893 |
Methods and compositions for maximizing the prevention and/or reduction of various maladies and drug side-effects using uridine |
William A. Garland, Philip Liaw |
2025-09-23 |
| 12194043 |
Uridine phosphorylase inhibitors to treat or prevent pulmonary disease |
William A. Garland, Philip Liaw |
2025-01-14 |
| 12109222 |
Methods and compositions for treating mucositis |
William A. Garland, Philip Liaw |
2024-10-08 |
| 11945803 |
Modulators of RAS GTPase |
Annie L. Lennek, Stephen D. Yanofsky, Solomon Ungashe, William A. Garland, Philip Liaw |
2024-04-02 |
| 11446303 |
Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions |
William A. Garland, Heshan Peiris, Philip Liaw |
2022-09-20 |
| RE48253 |
Methotrexate adjuvants to reduce toxicity and methods for using the same |
William A. Garland, Travis Karg |
2020-10-13 |
| 9468613 |
Doxorubicin adjuvants to reduce toxicity and methods for using the same |
William A. Garland |
2016-10-18 |
| 9382287 |
Methotrexate adjuvants to reduce toxicity and methods for using the same |
William A. Garland, Travis Karg |
2016-07-05 |
| 9061038 |
Doxorubicin adjuvants to reduce toxicity and methods for using the same |
William A. Garland |
2015-06-23 |
| 8853227 |
Methotrexate adjuvants to reduce toxicity and methods for using the same |
William A. Garland, Travis Karg |
2014-10-07 |
| 8227517 |
Doxorubicin adjuvants to reduce toxicity and methods for using the same |
William A. Garland |
2012-07-24 |
| 7998967 |
Methotrexate adjuvants to reduce toxicity and methods for using the same |
William A. Garland, Travis Karg |
2011-08-16 |